Early Stage Health Technology Assessment for Precision Biomarkers in Oral Health and Systems Medicine

by Steuten, Lotte M.G.
Published in OMICS (2016)

A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers

by Oosterhoff, Marije, van der Maas, Marloes E., Steuten, Lotte M. G.
Published in Appl Health Econ Health Policy (2015)

Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study

by de Ligt, Kelly M., Witteveen, Annemieke, Siesling, Sabine, Steuten, Lotte M. G.
Published in BMC Cancer (2018)

Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands

by Miquel-Cases, Anna, Steuten, Lotte M. G., Rigter, Lisanne S., van Harten, Wim H.
Published in BMC Cancer (2016)

Quality of integrated chronic care measured by patient survey: identification, selection and application of most appropriate instruments

by Vrijhoef, Hubertus J. M., Berbee, Rieneke, Wagner, Edward H., Steuten, Lotte M. G.
Published in Health Expect (2009)

Cost-Effectiveness Analysis of a Procalcitonin-Guided Decision Algorithm for Antibiotic Stewardship Using Real-World U.S. Hospital Data

by Voermans, Anne M., Mewes, Janne C., Broyles, Michael R., Steuten, Lotte M. G.
Published in OMICS (2019)

Effectiveness of Multidimensional Cancer Survivor Rehabilitation and Cost-Effectiveness of Cancer Rehabilitation in General: A Systematic Review

by Mewes, Janne C., Steuten, Lotte M.G., IJzerman, Maarten J., van Harten, Wim H.
Published 2012

COPD as a multicomponent disease: Inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care

by Steuten, Lotte M.G., Creutzberg, Eva C., Vrijhoef, Hubertus J.M., Wouters, Emiel F.
Published in Prim Care Respir J (2006)

Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients

by Miquel-Cases, Anna, Retèl, Valesca P., Lederer, Bianca, von Minckwitz, Gunter, Steuten, Lotte M. G., van Harten, Wim H.
Published in PLoS One (2016)

Comparative cost-effectiveness of focal and total salvage (125)I brachytherapy for recurrent prostate cancer after primary radiotherapy

by Peters, Max, Piena, Marjanne A., Steuten, Lotte M.G., van der Voort van Zyp, Jochem R.N., Moerland, Marinus A., van Vulpen, Marco
Published in J Contemp Brachytherapy (2016)

A Call for Pharmacogenovigilance and Rapid Falsification in the Age of Big Data: Why not First Road Test Your Biomarker?

by Şardaş, Semra, Endrenyi, Laszlo, Gürsoy, Ulvi K., Hutz, Mara, Lin, Biaoyang, Patrinos, George P., Steuten, Lotte M.G., Wang, Wei, Warnich, Louise, Özdemir, Vural
Published in OMICS (2014)

Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation

by Retèl, Valesca P., Steuten, Lotte M. G., Geukes Foppen, Marnix H., Mewes, Janne C., Lindenberg, Melanie A., Haanen, John B. A. G., van Harten, Wim H.
Published in BMC Cancer (2018)

Return-to-work intervention for cancer survivors: budget impact and allocation of costs and returns in the Netherlands and six major EU-countries

by Mewes, Janne C., Steuten, Lotte M. G., Groeneveld, Iris F., de Boer, Angela G. E. M., Frings-Dresen, Monique H. W., IJzerman, Maarten J., van Harten, Wim H.
Published in BMC Cancer (2015)

The Effectiveness of Chronic Care Management for Heart Failure: Meta-Regression Analyses to Explain the Heterogeneity in Outcomes

by Drewes, Hanneke W, Steuten, Lotte M G, Lemmens, Lidwien C, Baan, Caroline A, Boshuizen, Hendriek C, Elissen, Arianne M J, Lemmens, Karin M M, Meeuwissen, Jolanda A C, Vrijhoef, Hubertus J M
Published 2012